APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Propofol Medium/Long Chain Fat Emulsion Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Propofol Medium/Long Chain Fat Emulsion Injection Market Outlook and Growth Opportunities 2026

Report ID 174029180429 December 2025194 pages

Choose your research edition.

Industry ResearchPropofol Medium/Long Chain Fat Emulsion Injection Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Propofol Medium/Long Chain Fat Emulsion Injection Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Propofol Medium/Long Chain Fat Emulsion Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propofol Medium/Long Chain Fat Emulsion Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Propofol Medium/Long Chain Fat Emulsion Injection Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Propofol Medium/Long Chain Fat Emulsion Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Propofol Medium/Long Chain Fat Emulsion Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Propofol Medium/Long Chain Fat Emulsion Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Propofol Medium/Long Chain Fat Emulsion Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Propofol Medium/Long Chain Fat Emulsion Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Propofol Medium/Long Chain Fat Emulsion Injection market include Pfizer, AstraZeneca, Wellona Pharma, Rusoma Laboratories, Neon Laboratories Limited, Fresenius Kabi Deutschland GmbH, Centurion Healthcare Private Limited and B.Braun Melsungen AG, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Propofol Medium/Long Chain Fat Emulsion Injection market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Propofol Medium/Long Chain Fat Emulsion Injection and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Propofol Medium/Long Chain Fat Emulsion Injection revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Propofol Medium/Long Chain Fat Emulsion Injection market.

Propofol Medium/Long Chain Fat Emulsion Injection Segment by Company

Pfizer

AstraZeneca

Wellona Pharma

Rusoma Laboratories

Neon Laboratories Limited

Fresenius Kabi Deutschland GmbH

Centurion Healthcare Private Limited

B.Braun Melsungen AG

Propofol Medium/Long Chain Fat Emulsion Injection Segment by Type

10ml：0.1g

20ml：0.2g

50ml：0.5g

100ml：1.0g

Others

Propofol Medium/Long Chain Fat Emulsion Injection Segment by Application

Hospital

Clinic

Others

Propofol Medium/Long Chain Fat Emulsion Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Propofol Medium/Long Chain Fat Emulsion Injection status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Propofol Medium/Long Chain Fat Emulsion Injection key companies, revenue, market share, and recent developments.

3. To split the Propofol Medium/Long Chain Fat Emulsion Injection breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Propofol Medium/Long Chain Fat Emulsion Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Propofol Medium/Long Chain Fat Emulsion Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Propofol Medium/Long Chain Fat Emulsion Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Medium/Long Chain Fat Emulsion Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propofol Medium/Long Chain Fat Emulsion Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Medium/Long Chain Fat Emulsion Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Propofol Medium/Long Chain Fat Emulsion Injection industry.

Chapter 3: Detailed analysis of Propofol Medium/Long Chain Fat Emulsion Injection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Propofol Medium/Long Chain Fat Emulsion Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Propofol Medium/Long Chain Fat Emulsion Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Propofol Medium/Long Chain Fat Emulsion Injection Industry Trends Table 2. Propofol Medium/Long Chain Fat Emulsion Injection Industry Drivers Table 3. Propofol Medium/Long Chain Fat Emulsion Injection Industry Opportunities and Challenges Table 4. Propofol Medium/Long Chain Fat Emulsion Injection Industry Restraints Table 5. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Company (2021-2026) Table 7. Global Propofol Medium/Long Chain Fat Emulsion Injection Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Propofol Medium/Long Chain Fat Emulsion Injection Key Company Manufacturing Base & Headquarters Table 9. Global Propofol Medium/Long Chain Fat Emulsion Injection Company, Product Type & Application Table 10. Global Propofol Medium/Long Chain Fat Emulsion Injection Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Propofol Medium/Long Chain Fat Emulsion Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 10ml：0.1g Table 15. Significant Companies of 20ml：0.2g Table 16. Significant Companies of 50ml：0.5g Table 17. Significant Companies of 100ml：1.0g Table 18. Significant Companies of Others Table 19. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type (2021-2026) Table 23. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospital Table 25. Significant Companies of Clinic Table 26. Significant Companies of Others Table 27. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application (2021-2026) Table 31. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application (2027-2032) Table 32. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Region (2021-2026) Table 35. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Region (2027-2032) Table 37. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Market Share by Country (2021-2026) Table 40. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Market Share by Country (2027-2032) Table 42. Pfizer Company Information Table 43. Pfizer Business Overview Table 44. Pfizer Propofol Medium/Long Chain Fat Emulsion Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Pfizer Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio Table 46. Pfizer Recent Development Table 47. AstraZeneca Company Information Table 48. AstraZeneca Business Overview Table 49. AstraZeneca Propofol Medium/Long Chain Fat Emulsion Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. AstraZeneca Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio Table 51. AstraZeneca Recent Development Table 52. Wellona Pharma Company Information Table 53. Wellona Pharma Business Overview Table 54. Wellona Pharma Propofol Medium/Long Chain Fat Emulsion Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Wellona Pharma Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio Table 56. Wellona Pharma Recent Development Table 57. Rusoma Laboratories Company Information Table 58. Rusoma Laboratories Business Overview Table 59. Rusoma Laboratories Propofol Medium/Long Chain Fat Emulsion Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Rusoma Laboratories Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio Table 61. Rusoma Laboratories Recent Development Table 62. Neon Laboratories Limited Company Information Table 63. Neon Laboratories Limited Business Overview Table 64. Neon Laboratories Limited Propofol Medium/Long Chain Fat Emulsion Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Neon Laboratories Limited Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio Table 66. Neon Laboratories Limited Recent Development Table 67. Fresenius Kabi Deutschland GmbH Company Information Table 68. Fresenius Kabi Deutschland GmbH Business Overview Table 69. Fresenius Kabi Deutschland GmbH Propofol Medium/Long Chain Fat Emulsion Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Fresenius Kabi Deutschland GmbH Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio Table 71. Fresenius Kabi Deutschland GmbH Recent Development Table 72. Centurion Healthcare Private Limited Company Information Table 73. Centurion Healthcare Private Limited Business Overview Table 74. Centurion Healthcare Private Limited Propofol Medium/Long Chain Fat Emulsion Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Centurion Healthcare Private Limited Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio Table 76. Centurion Healthcare Private Limited Recent Development Table 77. B.Braun Melsungen AG Company Information Table 78. B.Braun Melsungen AG Business Overview Table 79. B.Braun Melsungen AG Propofol Medium/Long Chain Fat Emulsion Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. B.Braun Melsungen AG Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio Table 81. B.Braun Melsungen AG Recent Development Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Propofol Medium/Long Chain Fat Emulsion Injection Product Image Figure 2. Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Propofol Medium/Long Chain Fat Emulsion Injection Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 10ml：0.1g Image Figure 8. 20ml：0.2g Image Figure 9. 50ml：0.5g Image Figure 10. 100ml：1.0g Image Figure 11. Others Image Figure 12. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type (2021-2032) Figure 15. Hospital Image Figure 16. Clinic Image Figure 17. Others Image Figure 18. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application (2021-2032) Figure 21. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Propofol Medium/Long Chain Fat Emulsion Injection Sales Value (2021-2032) & (US$ Million) Figure 24. North America Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Propofol Medium/Long Chain Fat Emulsion Injection Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Propofol Medium/Long Chain Fat Emulsion Injection Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Propofol Medium/Long Chain Fat Emulsion Injection Sales Value (2021-2032) & (US$ Million) Figure 30. South America Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Propofol Medium/Long Chain Fat Emulsion Injection Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • 10ml：0.1g
  • 20ml：0.2g
  • 50ml：0.5g
  • 100ml：1.0g
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Pfizer
  • AstraZeneca
  • Wellona Pharma
  • Rusoma Laboratories
  • Neon Laboratories Limited
  • Fresenius Kabi Deutschland GmbH
  • Centurion Healthcare Private Limited
  • B.Braun Melsungen AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Propofol Medium/Long Chain Fat Emulsion Injection Market Dynamics
  1. 2.1 Propofol Medium/Long Chain Fat Emulsion Injection Industry Trends
  2. 2.2 Propofol Medium/Long Chain Fat Emulsion Injection Industry Drivers
  3. 2.3 Propofol Medium/Long Chain Fat Emulsion Injection Industry Opportunities and Challenges
  4. 2.4 Propofol Medium/Long Chain Fat Emulsion Injection Industry Restraints
3 Propofol Medium/Long Chain Fat Emulsion Injection Market by Company
  1. 3.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Company Revenue Ranking in 2025
  2. 3.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Company (2021-2026)
  3. 3.3 Global Propofol Medium/Long Chain Fat Emulsion Injection Company Ranking (2024-2026)
  4. 3.4 Global Propofol Medium/Long Chain Fat Emulsion Injection Company Manufacturing Base and Headquarters
  5. 3.5 Global Propofol Medium/Long Chain Fat Emulsion Injection Company Product Type and Application
  6. 3.6 Global Propofol Medium/Long Chain Fat Emulsion Injection Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Propofol Medium/Long Chain Fat Emulsion Injection Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Propofol Medium/Long Chain Fat Emulsion Injection Market by Type
  1. 4.1 Propofol Medium/Long Chain Fat Emulsion Injection Type Introduction
  2. 4.1.1 10ml：0.1g
  3. 4.1.2 20ml：0.2g
  4. 4.1.3 50ml：0.5g
  5. 4.1.4 100ml：1.0g
  6. 4.1.5 Others
  7. 4.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Type
  8. 4.2.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Type (2021-2032)
  10. 4.2.3 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type (2021-2032)
5 Propofol Medium/Long Chain Fat Emulsion Injection Market by Application
  1. 5.1 Propofol Medium/Long Chain Fat Emulsion Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Application
  6. 5.2.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Application (2021-2032)
  8. 5.2.3 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application (2021-2032)
6 Propofol Medium/Long Chain Fat Emulsion Injection Regional Value Analysis
  1. 6.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Region (2021-2032)
  3. 6.2.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Region: 2021-2026
  4. 6.2.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Propofol Medium/Long Chain Fat Emulsion Injection Sales Value (2021-2032)
  7. 6.3.2 North America Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Propofol Medium/Long Chain Fat Emulsion Injection Sales Value (2021-2032)
  10. 6.4.2 Europe Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Propofol Medium/Long Chain Fat Emulsion Injection Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Propofol Medium/Long Chain Fat Emulsion Injection Sales Value (2021-2032)
  16. 6.6.2 South America Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Propofol Medium/Long Chain Fat Emulsion Injection Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Country, 2025 VS 2032
7 Propofol Medium/Long Chain Fat Emulsion Injection Country-level Value Analysis
  1. 7.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Country (2021-2032)
  3. 7.2.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Country (2021-2026)
  4. 7.2.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Propofol Medium/Long Chain Fat Emulsion Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 AstraZeneca
  8. 8.2.1 AstraZeneca Company Information
  9. 8.2.2 AstraZeneca Business Overview
  10. 8.2.3 AstraZeneca Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AstraZeneca Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
  12. 8.2.5 AstraZeneca Recent Developments
  13. 8.3 Wellona Pharma
  14. 8.3.1 Wellona Pharma Company Information
  15. 8.3.2 Wellona Pharma Business Overview
  16. 8.3.3 Wellona Pharma Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Wellona Pharma Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
  18. 8.3.5 Wellona Pharma Recent Developments
  19. 8.4 Rusoma Laboratories
  20. 8.4.1 Rusoma Laboratories Company Information
  21. 8.4.2 Rusoma Laboratories Business Overview
  22. 8.4.3 Rusoma Laboratories Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Rusoma Laboratories Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
  24. 8.4.5 Rusoma Laboratories Recent Developments
  25. 8.5 Neon Laboratories Limited
  26. 8.5.1 Neon Laboratories Limited Company Information
  27. 8.5.2 Neon Laboratories Limited Business Overview
  28. 8.5.3 Neon Laboratories Limited Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Neon Laboratories Limited Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
  30. 8.5.5 Neon Laboratories Limited Recent Developments
  31. 8.6 Fresenius Kabi Deutschland GmbH
  32. 8.6.1 Fresenius Kabi Deutschland GmbH Company Information
  33. 8.6.2 Fresenius Kabi Deutschland GmbH Business Overview
  34. 8.6.3 Fresenius Kabi Deutschland GmbH Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fresenius Kabi Deutschland GmbH Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
  36. 8.6.5 Fresenius Kabi Deutschland GmbH Recent Developments
  37. 8.7 Centurion Healthcare Private Limited
  38. 8.7.1 Centurion Healthcare Private Limited Company Information
  39. 8.7.2 Centurion Healthcare Private Limited Business Overview
  40. 8.7.3 Centurion Healthcare Private Limited Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Centurion Healthcare Private Limited Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
  42. 8.7.5 Centurion Healthcare Private Limited Recent Developments
  43. 8.8 B.Braun Melsungen AG
  44. 8.8.1 B.Braun Melsungen AG Company Information
  45. 8.8.2 B.Braun Melsungen AG Business Overview
  46. 8.8.3 B.Braun Melsungen AG Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (2021-2026)
  47. 8.8.4 B.Braun Melsungen AG Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
  48. 8.8.5 B.Braun Melsungen AG Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst